戻る Agenda
Special Session-2 : Consider the Future of the Pharmaceutical Industry. ~What value can DIA Create?
Session Chair(s)
Hideki Oi, RPH
Clinical Research Center, Kyorin University Hospital, Japan
Keisuke Suzuki, PHD
Director, Innovation Center for Translational Research, National Center for Geriatrics and Gerontology, Japan
Speaker(s)
Manabu Hirashima, RPH
Chief Pharmacist, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Japan
Issues with the Drug Use-Results Surveys Revealed through a Nationwide Questionnaire Survey of Hospitals and Pharmaceutical Companies
Makoto Miyazaki, MSC
, Japan Pharmaceutical Manufacturers Association (JPMA) / MSD K.K. , Japan
Status on Post-Marketing Surveillance, after Revision of Good Post-Marketing Study Practice.
Megumu Yokono
Associate Professor of Medical law, School of Social Sciences,, Waseda University, Japan
Yumiko Nomura
Director, Office of Clinical Trial Promotion, Ministry of Health, Labour and Welfare (MHLW), Japan
Nao Moriyama
Center for Clinical Research & Trial , Teikyo University Hospital, Japan
Mami Yoshioka
Chief Manager of Clinical trial unit,Healthy Aging Innovation Center, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Japan